Chinese Regulatory Changes for Human Serum and Plasma Exports Trigger Potential Delays

11 June 2010 by World Courier

Researchers conducting or planning to conduct clinical trials in China should be aware of new regulatory changes that specifically affect export shipments of human serum and plasma from China and the delays that the new administrative process may create.

Download this free white paper to find out more.